TRANSLATING THERAPIES FOR VISION LOSS

Group Bence Gyorgy | Gene editing | Optogenetics | Clinial Studies | IOB Basel

LATEST NEWS

gyorgyben

Welcome Jay Zoellin!

Jay joins us a PhD student under IOB's MD-PhD program. Jay Zoellin's research project aims to address a critical gap in current medical...

gyorgyben

Paper published on Bioarchives

We published our base editing paper on Bioarchives. https://www.biorxiv.org/content/10.1101/2023.04.17.535579v1

gyorgyben

RhyGaze AG launches

The first IOB spinout RhyGaze AG starts operations in Basel, Switzerland. RhyGaze AG will develop the cone-targeted optogenetic approach...

OUR RESEARCH

Gene editing

Gene editing is a powerful technique that allows researchers to perform targeted modifications in the genome. We use gene editing to treat diseases of the eye.

Learn more

Optogenetics

Optogenetics is a biological technique to control the activity of cells using light. This technique can be used to make the blind eye to become light sensitive again.

Learn more about projects

Clinical Research

In order to develop and translate therapies, it is essential to study humans. This is why we are engaged in clinical research, which support our translational projects.

Learn more about projects